New Jersey Small Business Grants 2026
New Jersey's standout program is its Research & Development Tax Credit — fully refundable with no statewide cap, one of the most pre-revenue-friendly state R&D incentives in the eastern US. The New Jersey Economic Development Authority (NJEDA) runs the rest of the state toolkit: job-creation tax credits, a Net Operating Loss transfer program for tech and biotech companies, and a lease grant for small businesses signing new commercial space.
Answer a few quick questions and watch the map narrow to the 275 programs a New Jersey business can actually win — federal, state & local, free and no account.
- Free
- No account needed
- 660+ programs, verified June 2026
Start with the New Jersey Research & Development Tax Credit: fully refundable and uncapped, it pays qualifying research-active businesses cash even at zero New Jersey tax liability. Pair it with the federal Section 41 payroll-tax offset (up to $500,000/yr) on the same research wages. Growth-stage tech and biotech companies without taxable income should also look at the NJEDA Technology Business Tax Certificate Transfer (NOL) Program, which lets them sell unused losses and credits for cash, up to $20,000,000 lifetime. Job-creators aiming for 35+ new hires should evaluate NJEDA Emerge, and businesses signing a new lease can apply for the NJEDA Small Business Lease Grant (two payments of 20% of annual lease cost). New Jersey's pharma corridor — Morris, Somerset, Middlesex, and Mercer counties — is one of the richest NIH SBIR geographies in the country.
The funding landscape in New Jersey
New Jersey's economy centers on one of the densest pharmaceutical and life-sciences R&D corridors in the world — Morris, Somerset, Middlesex, and Mercer counties host major operations tied to companies including Johnson & Johnson, Sanofi, and Daiichi Sankyo, plus biotech spinouts from Rutgers University and Princeton University. North Jersey (Bergen, Hudson, Essex counties) carries a large financial-services and fintech economy anchored by proximity to New York City, while South Jersey (Camden, Atlantic, Cumberland, Salem counties) has a more industrial and agricultural profile. The New Jersey Economic Development Authority (NJEDA, njeda.gov) is the state's central business-financing agency, and its programs lean toward tax credits and lease/loan support rather than direct cash grants.
The New Jersey R&D Tax Credit is the strongest state-level lever for research-active businesses of any size: it is fully refundable at 10% of incremental qualified research expense, with no statewide cap and no minimum operating history, so a pre-revenue company gets paid in cash. NJEDA's Technology Business Tax Certificate Transfer Program lets tech and biotech companies without taxable income monetize unused Net Operating Losses and R&D credits instead, up to $20,000,000 over the company's lifetime. For job creation, NJEDA Emerge offers per-job Corporation Business Tax credits to companies adding at least 35 net new New Jersey jobs (lower thresholds in targeted growth sectors and distressed communities). Businesses signing a new commercial lease can apply for the NJEDA Small Business Lease Grant, worth two payments of 20% of the annual lease cost.
New Jersey has fewer state-specific programs than New York or Connecticut, more than Delaware
New Jersey's 11 state-specific programs place it toward the lean end among its Northeast neighbors: New York has 29 in the same catalog, Connecticut 18, Pennsylvania 14, and Delaware just 5. The far larger pool for any New Jersey business is the 264 national programs open to every state — the practical difference between the two tiers is explained in our federal vs state grants guide.
All 11 New Jersey-specific programs, in one table
The GrantCompass catalog tracks 11 programs available specifically (or regionally) to New Jersey businesses: 4 run by NJEDA, 1 by the New Jersey Division of Taxation, and 6 by multi-state mission lenders and a federal home loan bank serving New Jersey among other states. Only 2 are direct grants — New Jersey's state strategy runs on tax credits and lending. Click any program for its full profile, eligibility rules, and application steps.
| Program | Run by | Type | Max funding | Best for |
|---|---|---|---|---|
| Technology Business Tax Certificate Transfer (NOL) | NJEDA | Tax credit | Up to $20M lifetime | Pre-revenue tech/biotech companies with unused losses |
| Next New Jersey Manufacturing Program Tax Credit | NJEDA | Tax credit | Up to 25% of capital investment | Large manufacturing capital investments |
| LISC Entrepreneurs of Color Fund | LISC | Loan | Up to $500,000+ | Entrepreneurs of color across 11 states incl. NJ |
| Pursuit — CDFI Small Business Loans | Pursuit (CDFI) | Loan | $10,000–$500,000 | NJ/NY/CT/PA/IL/DE businesses needing flexible CDFI credit |
| NJ Accelerate — NJEDA Accelerator Matching | NJEDA | Loan | Up to $250K loan + rent | Startups in an approved accelerator program |
| New Jersey R&D Tax Credit | NJ Division of Taxation | Tax credit | 10% of incremental QRE, refundable | Any R&D-active NJ business, pre- or post-revenue |
| Grameen America — Microloans | Grameen America | Loan | $2,000–$15,000 | Women entrepreneurs across 17 states incl. NJ |
| Ascendus — Term Loans & Microloans | Ascendus (CDFI) | Loan | Up to $100,000 | Owners with thin credit (FICO 575+ accepted) |
| Empowerment Zone Employment Credit | Internal Revenue Service | Tax credit | Up to $3,000/employee/yr | Employers hiring in designated NJ zones (21 states incl. NJ) |
| NJEDA Small Business Lease Grant | NJEDA | Grant | 2 × 20% of annual lease | Small businesses signing a new commercial lease |
| FHLBank NY — Small Business Recovery Grant | FHLBank New York | Grant | Up to $10,000 | Small NJ or NY businesses via a member bank |
Award ceilings span $10,000 to $20 million
The seven New Jersey programs with a published dollar ceiling cover three orders of magnitude, from the $10,000 FHLBNY grant to the $20,000,000 lifetime cap on the NJEDA NOL tech-transfer program. The pattern: the two direct grants are the smallest awards, and the credit/loan programs carry the real scale. The New Jersey R&D credit and the Next New Jersey manufacturing credit are excluded below because both are calculated as a percentage (of qualified research expense, or of capital investment) rather than a fixed dollar ceiling.
Positions on a logarithmic scale. The New Jersey R&D credit (percentage-based, uncapped), the Next New Jersey manufacturing credit (percentage of capital investment), and the Empowerment Zone Employment Credit (per-employee, per-year) are not plotted. Orange dot = grant, green = loans/loan-style, amber = tax credit.
- Loans & loan-style 5
- Tax credits 4
- Grants 2
Nationally, 56% of small-business funding programs are grants (see the US funding statistics report) — New Jersey inverts that mix at the state level, with under 20% grants. That is why the winning New Jersey strategy leans on the R&D credit stack and federal grants: SBIR, the Section 41 R&D credit, and the year-round national programs.
NJEDA and the Division of Taxation run five active New Jersey programs
The New Jersey Economic Development Authority (njeda.gov) administers four of the 11 state-specific programs: the NOL tech-transfer program, the Next New Jersey manufacturing credit, NJ Accelerate, and the Small Business Lease Grant. The New Jersey Division of Taxation administers the fifth — the R&D Tax Credit — filed with the annual Corporation Business Tax (CBT) return rather than through an NJEDA application.
New Jersey R&D Tax Credit: fully refundable, no cap, no minimum history
The New Jersey Research and Development Tax Credit is calculated at 10% of incremental qualified research expenses (QRE) conducted within New Jersey, using the same federal four-part test that defines qualifying research for the federal Section 41 credit. Three features distinguish it: it is fully refundable — if the credit exceeds a company's New Jersey CBT liability, the state pays the difference in cash, not a carry-forward; it carries no statewide cap, so it isn't competitively prorated when the program is oversubscribed; and it has no minimum operating history, so first-year New Jersey R&D businesses can claim it immediately. Applications are filed with the New Jersey Division of Taxation as part of the annual CBT return — documentation prepared for the federal Section 41 credit is directly reusable for the New Jersey filing.
NOL Tech-Transfer Program: sell your losses for cash, up to $20,000,000
The Technology Business Tax Certificate Transfer Program lets qualifying New Jersey technology and biotechnology companies sell unused Net Operating Losses and R&D tax credits to profitable New Jersey corporations for cash — solving the core problem of a tax credit or loss carry-forward that a pre-revenue company has no income to use. The GrantCompass catalog records the program's lifetime ceiling at up to $20,000,000 per company. It is administered by NJEDA and is one of the few state-level programs anywhere built specifically to monetize R&D losses for young life-science and technology companies before they reach profitability.
NJ Accelerate: up to $250,000 in loan plus subsidized rent
The NJ Accelerate program matches NJEDA funding to startups accepted into an approved New Jersey accelerator program, providing up to $250,000 in loan financing plus rent support for qualifying early-stage companies. It is designed to work alongside the accelerator's own mentorship and cohort structure rather than as a standalone application — the practical first step is applying to (or already being enrolled in) a participating accelerator.
Small Business Lease Grant: 40% of a year's rent, paid in two installments
The NJEDA Small Business Lease Grant pays two installments, each equal to 20% of the annual lease cost, to small New Jersey businesses signing a new commercial lease — effectively 40% of one year's rent returned over two payments. Check njeda.gov for current eligibility criteria and open application windows; grant programs of this type can pause and reopen by state funding year.
Next New Jersey Manufacturing Program: for large capital investments
The Next New Jersey Manufacturing Program Tax Credit provides up to 25% of qualifying capital investment as a Corporation Business Tax credit for large-scale New Jersey manufacturing projects. It is aimed at sizable capital deployments rather than typical small-business purchases — most small manufacturers will not meet the investment thresholds, but businesses planning a major New Jersey manufacturing expansion should evaluate it alongside NJEDA Emerge and the federal Section 45X production credit.
NJEDA Emerge: per-job credits for 35+ new hires
NJEDA Emerge is New Jersey's job-creation incentive, providing per-job Corporation Business Tax credits over a credit period of up to 7 years. Businesses generally need to create at least 35 net new full-time New Jersey jobs — lower thresholds, as few as 10 jobs, apply in targeted growth sectors (life sciences, advanced manufacturing, clean energy, technology, finance/insurance) and in Opportunity Zone or distressed-community locations, particularly across South Jersey. Applications must be submitted to and approved by NJEDA before the qualifying investment is made — engage NJEDA for a pre-application consultation if your growth plan is in range.
| Feature | New Jersey R&D Credit | Federal Section 41 |
|---|---|---|
| Status in 2026 | Active | Active |
| Value | 10% of incremental NJ QRE, fully refundable | Up to $500,000/yr payroll-tax offset for qualified small businesses |
| Cap | None (not competitively prorated) | $500,000/yr cap on the QSB payroll-tax offset |
| What to do | File with your annual NJ Corporation Business Tax return | File Form 6765 with your federal return; stack on the same NJ QRE base |
Six more New Jersey programs come from CDFIs and a federal home loan bank
Beyond NJEDA and the Division of Taxation, the catalog tracks one IRS employment credit and five mission-lender programs that reach New Jersey as one of several states served. For many New Jersey owners — especially those a bank has declined — these move faster and are more forgiving than any state-run program.
Pursuit lends $10,000–$500,000 across six Northeast states
Pursuit is a CDFI lending $10,000 to $500,000 to small businesses across New York, New Jersey, Connecticut, Pennsylvania, Illinois, and Delaware. It is a flexible option for New Jersey borrowers whose deal size sits between what a microloan can cover and what conventional bank underwriting will approve.
LISC's Entrepreneurs of Color Fund targets underserved owners, up to $500,000+
The LISC Entrepreneurs of Color Fund lends up to $500,000 or more to entrepreneurs of color across 11 states including New Jersey, part of the Local Initiatives Support Corporation's broader small-business lending network. It is one of the largest underserved-owner-focused loan products reaching New Jersey.
Grameen America and Ascendus serve early-stage and thin-credit owners
Grameen America offers microloans of $2,000–$15,000 exclusively to women entrepreneurs, reaching New Jersey among 17 states. Ascendus, a national CDFI operating in 49 states including New Jersey, offers term loans and microloans up to $100,000 with a deliberately low bar — FICO scores as low as 575 are accepted. For a New Jersey owner rebuilding credit or just starting out, these two are often the realistic first rungs before NJ Accelerate- or bank-scale financing.
FHLBank New York pays up to $10,000 through a member bank
The FHLBank New York Small Business Recovery Grant provides up to $10,000 to small businesses in New York and New Jersey, distributed through a participating FHLBNY member financial institution rather than a direct state or federal application. Ask your bank whether it participates in FHLBNY community programs before assuming this one isn't accessible to you.
The Empowerment Zone Employment Credit rewards hiring in designated tracts
The federal Empowerment Zone Employment Credit is worth up to $3,000 per qualifying employee per year for businesses in designated Empowerment Zone census tracts across 21 states, including parts of New Jersey. It rewards ongoing employment rather than a one-time award, so it compounds with every qualifying hire retained year over year.
Federal & national programs New Jersey businesses can use
These programs are open to qualifying small businesses in every state, including New Jersey — often the largest non-dilutive dollars available, and especially relevant given New Jersey's pharmaceutical R&D density. The catalog counts 264 national programs open to New Jersey businesses — 24× the state-specific list. NIH SBIR Phase I reaches $323,090; see the biggest grants ranking for what a small business can realistically win.
SBIR Phase I — NIH (PHS Omnibus)
A 6-month feasibility grant peer-reviewed by NIH study section — the primary non-dilutive target for NJ's pharma corridor in oncology, infectious disease, cardiovascular, and rare-disease research.
SBIR Phase I — NSF (America's Seed Fund)
Deep-tech grant via a short Project Pitch entry point — the better fit for Princeton, Rutgers, and NJIT spinouts in computer science, materials science, and engineering.
SBIR Phase I — Department of Defense
Relevant for defense-adjacent New Jersey companies near the Fort Dix/Joint Base McGuire-Dix-Lakehurst corridor.
Research & Development Tax Credit (Section 41)
Federal R&D credit offsetting up to $500K/yr in payroll taxes for Qualified Small Businesses — stacks directly on the same NJ R&D wages as the state credit.
Advanced Manufacturing Production Credit (Section 45X)
Per-unit production credit for US manufacturers of solar, battery, and critical-mineral components — relevant to NJ's Meadowlands and South Jersey industrial manufacturers, plus the offshore-wind supply chain off the Jersey Shore.
Energy Investment Tax Credit (Section 48/48E)
Covers solar, storage, geothermal, and CHP installations; energy-community census tracts in southern NJ (Salem, Cumberland, Camden, Atlantic City) may qualify for a +10% bonus adder.
SBA 7(a) Loan Program
SBA's flagship loan guarantee — up to $5M for almost any business purpose through an SBA-approved New Jersey lender.
SBA Microloan Program
Loans up to $50K for startups and small businesses through local nonprofit intermediaries, including New Jersey CDFIs. Apply through the intermediary, not SBA directly.
Choosing between the two big SBA loans? The 7(a) vs 504 comparison covers when each wins. If you want the most winnable national money first, start with the easiest grants to get and microgrants under $10,000 — many accept applications year-round.
The right New Jersey program depends on your business profile
New Jersey's 11 programs sort cleanly by who they serve. Several of the multi-state mission lenders reaching New Jersey explicitly target underserved owners, while the NJEDA programs are gated by job creation, capital investment size, or R&D activity.
Pharmaceutical and biotech companies
New Jersey's pharma corridor — spanning Morris, Somerset, Middlesex, and Mercer counties — should treat NIH SBIR Phase I (up to $323,090) as the primary non-dilutive grant target, matched to the right NIH institute. Layer the federal Section 41 QSB payroll-tax offset (up to $500,000/yr) plus the fully refundable New Jersey R&D credit on the same qualifying wages. Pre-revenue companies without taxable income should evaluate the NOL tech-transfer program (up to $20M lifetime) to monetize losses instead of waiting for profitability.
Tech and deep-tech founders
Princeton, Rutgers, and NJIT spinout companies in computer science, materials science, and engineering fit NSF SBIR (up to $305,000) better than NIH, since NSF does not cover the biomedical domains NIH already funds. Startups accepted into a participating accelerator should apply for NJ Accelerate (up to $250,000 loan plus rent support). The federal Section 41 credit plus the New Jersey R&D credit apply equally to qualifying software R&D — externally-sold or embedded software development typically qualifies; internal-use administrative software generally does not.
Manufacturers and clean-energy installers
New Jersey manufacturers installing on-site solar, storage, or CHP should combine the federal Section 48/48E ITC (30%, plus a possible +10% energy-community bonus in parts of southern NJ) with New Jersey's own BPU-administered solar incentives. Manufacturers producing eligible clean-energy components should evaluate the federal Section 45X per-unit production credit. Large-scale capital projects should evaluate the Next New Jersey Manufacturing credit (up to 25% of capital investment) alongside NJEDA Emerge.
Businesses creating 35+ New Jersey jobs
Companies planning a significant New Jersey hiring expansion — 35+ net new full-time jobs, or as few as 10 in targeted growth sectors and distressed communities — should engage NJEDA about Emerge before making the qualifying investment. Life sciences, advanced manufacturing, clean energy, technology, and finance/insurance sectors receive enhanced per-job credit amounts, and South Jersey Opportunity Zone locations receive higher credits than North Jersey.
Women-, minority-, and veteran-owned businesses
New Jersey does not run a large exclusive state grant program for these categories, but three multi-state mission lenders reaching New Jersey have an explicit underserved-owner focus: Grameen America (women entrepreneurs, $2,000–$15,000), the LISC Entrepreneurs of Color Fund (up to $500,000+), and Ascendus (FICO 575+ accepted). Federally, SBA Women's Business Centers and Veterans Business Outreach Centers operate across New Jersey, and SBA's 8(a) program provides federal contracting preferences. Dedicated national lists: women-owned, minority-owned, and veteran-owned business grants.
South Jersey and Opportunity Zone businesses
Camden, Atlantic City, Trenton, and other South Jersey communities carry significant Qualified Opportunity Zone designations, which sharpen the value of NJEDA Emerge's location-based bonus and can improve access to the CDFI lenders above. South Jersey's energy-community census tracts (Salem, Cumberland, parts of Camden) may also qualify for the +10% bonus adder on the federal Section 48/48E ITC.
Where you are in New Jersey changes the list
North Jersey — Bergen, Hudson, Essex, Union
Dense fintech and financial-services economy anchored by proximity to New York City. NJEDA Emerge applies at standard (not bonus) rates outside Opportunity Zone tracts. Pursuit and LISC both actively lend here.
Pharma corridor — Morris, Somerset, Middlesex, Mercer
The heart of New Jersey's life-sciences economy. NIH SBIR is the dominant grant; the fully refundable NJ R&D credit is especially valuable given the density of qualifying research wages.
Trenton metro — Mercer County
New Jersey's capital carries significant Opportunity Zone designations; NJEDA Emerge's location-based bonus applies. Ascendus and Pursuit both lend into Trenton.
South Jersey industrial — Camden, Gloucester, Burlington, Salem, Cumberland
Agricultural processing and industrial manufacturing. Energy-community bonus adders under federal ITC may apply near former industrial and nuclear-adjacent sites in Salem County.
Atlantic City and the shore — Atlantic, Cape May
Hospitality/gaming economy plus an emerging offshore-wind supply chain off the Jersey Shore — potential relevance for Section 45X component manufacturers.
Which New Jersey program to pursue first
Match the program to your situation, not the other way around. Each branch below is the highest-value first move for that profile.
→ file the fully refundable New Jersey R&D credit alongside the federal Section 41 QSB payroll-tax offset. No cap, no minimum history, no application window to miss.
→ evaluate the NOL Tech-Transfer Program (up to $20M lifetime) to sell losses and credits for cash instead of waiting on a carry-forward.
→ NIH SBIR Phase I is your primary grant (up to $323,090). Match your science to the right NIH institute before applying.
→ Ascendus (FICO 575+, up to $100,000) or Pursuit ($10,000–$500,000) before the SBA Microloan.
→ apply for the NJEDA Small Business Lease Grant (two payments of 20% of annual lease cost) before you sign, if the timing works with NJEDA's process.
→ NJEDA Emerge — engage NJEDA for a pre-application consultation before committing to the qualifying investment.
Worked example: a Middlesex County biotech startup
A pre-revenue biotech company with $1.2M in qualifying New Jersey research wages and a small team assembles the following stack, using each program's published numbers:
| Move | Program | What the published numbers say |
|---|---|---|
| Non-dilutive feasibility funding | NIH SBIR Phase I | Up to $323,090 for a 6-month feasibility study, matched to the right NIH institute |
| Payroll-tax offset on R&D wages | Federal Section 41 (QSB) | Up to $500,000/yr offset directly against Form 941 payroll taxes |
| State R&D cash refund on the same wages | New Jersey R&D credit | 10% of incremental NJ QRE, fully refundable in cash, no cap |
| Monetize unused losses before profitability | NOL Tech-Transfer Program | Sell losses/credits for cash, up to $20,000,000 lifetime |
Every rung is non-competitive or lightly competitive except the SBIR grant itself — that is the practical difference between New Jersey's credit-led stack and chasing a single famous grant.
How to apply in New Jersey
NJEDA programs (NOL tech-transfer, Next New Jersey manufacturing, NJ Accelerate, Small Business Lease Grant, Emerge) are administered through njeda.gov, while the R&D credit is filed with the Division of Taxation — each has a different front door. Work the sequence below.
Map your eligibility first. Run the free GrantCompass eligibility check (~6 questions) to see all New Jersey + national programs your business matches before spending time on any single application.
File the R&D credit with your CBT return. Both the New Jersey R&D credit and the federal Section 41 credit use the same four-part test and the same qualified research expense base — prepare the documentation once and use it for both filings.
Pre-revenue with unused losses? Contact NJEDA about the NOL program early. The Technology Business Tax Certificate Transfer Program has an application and certification process — start well before you need the cash.
Pharma or biotech: match your science to the right NIH institute before drafting. NCI for oncology, NIAID for infectious disease, NHLBI for cardiovascular, NCATS for rare disease — the wrong institute match is the single most common SBIR mistake.
Job-creators: engage NJEDA before committing to the expansion. Emerge requires application and conditional approval before the qualifying investment is made — approaching NJEDA after the fact forfeits eligibility.
Layer the federal and CDFI stack. SBA loans, SBIR, and mission lenders like Ascendus and Pursuit run through standard federal and lender portals — they stack with every state program above.
Five mistakes New Jersey applicants make
- Assuming the New Jersey R&D credit needs a separate application process. It's filed with your annual Corporation Business Tax return, not a standalone NJEDA program.
- Waiting for profitability before considering the NOL tech-transfer program. The program exists specifically because pre-revenue companies can't use losses they have no income to offset against.
- Signing a commercial lease before checking the Small Business Lease Grant. Confirm current NJEDA eligibility and timing before you sign, since the window can matter.
- Committing to a hiring expansion before applying for Emerge. NJEDA requires application and conditional approval before the qualifying investment is made.
- Submitting NIH SBIR to the wrong institute. Match your science to NCI, NIAID, NHLBI, or NCATS before drafting — misalignment is the most common avoidable rejection reason.
New Jersey small business funding FAQ
What small business grants are available in New Jersey in 2026?
New Jersey's state toolkit is tax-credit and loan-heavy rather than grant-heavy — of the 11 New Jersey-specific programs in the GrantCompass catalog, 4 are tax credits, 5 are loans, and only 2 are direct grants: the FHLBank New York Small Business Recovery Grant (up to $10,000, also open to New York) and the NJEDA Small Business Lease Grant (two payments of 20% of annual lease cost). The standout program for R&D-active companies is the New Jersey Research and Development Tax Credit, which is fully refundable with no statewide cap. Most New Jersey businesses find their largest grant dollars in the 264 national programs also open to New Jersey, especially NIH SBIR Phase I (up to $323,090) for the state's pharmaceutical corridor.
Why is New Jersey's R&D tax credit considered strong for pre-revenue companies?
New Jersey's R&D Tax Credit is calculated on qualified research expenses conducted in New Jersey and is fully refundable — if the credit exceeds a company's New Jersey Corporation Business Tax liability, the state pays the difference in cash, at 10% of incremental qualified research expense. There is no statewide cap on the program, so it is not competitively prorated the way capped state credits are. That combination (refundable, uncapped) is what makes it valuable to pre-revenue New Jersey R&D companies, which can pair it with the federal Qualified Small Business payroll-tax offset on the same underlying research wages.
What is the NJEDA Technology Business Tax Certificate Transfer (NOL) Program?
It is a program that lets qualifying New Jersey technology and biotechnology companies sell unused Net Operating Losses (NOLs) and R&D tax credits to profitable New Jersey corporations for cash, since a pre-revenue company can't use tax losses it has no income to offset. The GrantCompass catalog records the program's lifetime ceiling at up to $20,000,000 per company. It is one of the few state-level tools in the country built specifically to monetize R&D losses for young life-science and technology companies before they have taxable income.
What is the NJEDA Small Business Lease Grant?
The NJEDA Small Business Lease Grant helps small New Jersey businesses cover the cost of a new commercial lease. Per the GrantCompass catalog, it pays two installments, each equal to 20% of the annual lease cost — effectively 40% of one year's rent returned over two payments. It is administered by the New Jersey Economic Development Authority (NJEDA); check njeda.gov for current eligibility criteria and open application windows, since state grant programs like this one can pause and reopen by funding year.
What SBIR funding is available for New Jersey pharmaceutical and biotech companies?
New Jersey's pharmaceutical corridor — spanning Morris, Somerset, Middlesex, and Mercer counties — is one of the most concentrated pharmaceutical R&D geographies in the world. NIH SBIR Phase I reaches up to $323,090 for a 6-month feasibility study, peer-reviewed by NIH institute (NCI for oncology, NIAID for infectious disease, NHLBI for cardiovascular, NCATS for rare disease). NSF SBIR, up to $305,000, is the better fit for Princeton, Rutgers, and NJIT spinouts working in computer science, materials science, and engineering rather than biomedicine — NSF does not fund the biomedical domains NIH already covers.
Does New Jersey have a program like NJEDA Emerge for job creation?
Yes — NJEDA Emerge is New Jersey's primary job-creation incentive, providing per-job Corporation Business Tax credits over a credit period of up to 7 years for businesses creating at least 35 net new full-time New Jersey jobs (lower thresholds apply in targeted growth sectors and in Opportunity Zone or distressed-community locations, particularly in South Jersey). Life sciences, advanced manufacturing, clean energy, technology, and finance/insurance sectors receive enhanced per-job credit amounts. Applications must be submitted to and approved by NJEDA before the qualifying investment is made.
Which CDFIs and mission lenders serve New Jersey small businesses?
Four multi-state mission lenders in the GrantCompass catalog serve New Jersey alongside neighboring states: Pursuit (a CDFI lending $10,000–$500,000 across NY, NJ, CT, PA, IL, and DE), LISC's Entrepreneurs of Color Fund (up to $500,000+ across 11 states including NJ, targeted at entrepreneurs of color), Grameen America (microloans of $2,000–$15,000 for women entrepreneurs across 17 states including NJ), and Ascendus (term loans up to $100,000 across 49 states, FICO scores as low as 575 accepted). These are typically faster and more forgiving than state-run programs for owners who don't qualify for conventional bank credit.
What this means for your New Jersey business
New Jersey's edge is a fully refundable, uncapped R&D credit — so the winning stack pairs it with the federal Section 41 payroll-tax offset and, for pharma/biotech, NIH SBIR. The free GrantCompass eligibility check maps all of it to your specific business in about six questions and generates your free matched report.